- Home
- LBRDA vs HALO Comparison
LBRDA vs HALO Comparison
Compare LBRDA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDA
- HALO
- Stock Information
- Founded
- LBRDA 2014
- HALO 1998
- Country
- LBRDA United States
- HALO United States
- Employees
- LBRDA N/A
- HALO N/A
- Industry
- LBRDA Cable & Other Pay Television Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBRDA Telecommunications
- HALO Health Care
- Exchange
- LBRDA Nasdaq
- HALO Nasdaq
- Market Cap
- LBRDA 8.3B
- HALO 7.6B
- IPO Year
- LBRDA N/A
- HALO N/A
- Fundamental
- Price
- LBRDA $60.25
- HALO $76.90
- Analyst Decision
- LBRDA Buy
- HALO Buy
- Analyst Count
- LBRDA 2
- HALO 8
- Target Price
- LBRDA $105.00
- HALO $70.25
- AVG Volume (30 Days)
- LBRDA 110.1K
- HALO 2.0M
- Earning Date
- LBRDA 11-06-2025
- HALO 10-30-2025
- Dividend Yield
- LBRDA N/A
- HALO N/A
- EPS Growth
- LBRDA 36.76
- HALO 68.93
- EPS
- LBRDA 7.58
- HALO 4.37
- Revenue
- LBRDA $1,052,000,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- LBRDA $6.59
- HALO $32.57
- Revenue Next Year
- LBRDA $2.22
- HALO $23.25
- P/E Ratio
- LBRDA $8.04
- HALO $17.65
- Revenue Growth
- LBRDA 7.24
- HALO 34.97
- 52 Week Low
- LBRDA $54.90
- HALO $42.01
- 52 Week High
- LBRDA $95.95
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- LBRDA 38.33
- HALO 77.94
- Support Level
- LBRDA $57.35
- HALO $74.52
- Resistance Level
- LBRDA $60.64
- HALO $76.28
- Average True Range (ATR)
- LBRDA 1.58
- HALO 1.63
- MACD
- LBRDA 0.67
- HALO -0.06
- Stochastic Oscillator
- LBRDA 48.41
- HALO 88.60
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.